• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝炎中回肠-肝脏轴的固有免疫反应性。

Innate immune reactivity of the ileum-liver axis in nonalcoholic steatohepatitis.

机构信息

Third Department of Internal Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.

出版信息

Dig Dis Sci. 2012 May;57(5):1144-51. doi: 10.1007/s10620-012-2073-z. Epub 2012 Feb 25.

DOI:10.1007/s10620-012-2073-z
PMID:22367065
Abstract

BACKGROUND

Over-proliferation and bacterial translocation of Gram-negative bacilli within the intestinal flora, and increased portal venous levels of endotoxins, are involved in nonalcoholic steatohepatitis (NASH).

AIM

To evaluate the innate immune response in the small intestine and liver using the rat NASH model.

METHODS

We produced the NASH model by administering a choline-deficient amino acid-defined diet to F344 rats. We analyzed the serum and liver tissue to assess the effects of innate immune reactivity in this NASH model.

RESULTS

Significant increases were detected in serum ALT levels and in the portal venous serum and whole-liver levels of TNF-α and IFN-γ in the NASH group. Strong Sirius red staining and TNF-α immune staining were seen in the NASH group, and real-time PCR revealed significantly increased expression of TNF-α and TLR4 mRNA in the NASH group. Higher TNF-α levels were detected in the Kupffer cells isolated culture supernatant in the NASH group than in the control group. Immune staining of the ileal tissue specimens resulted in greater staining of TNF-α, TLR4, and macrophage/dendritic cells, mainly in the submucosa, in the NASH group than in the control group.

CONCLUSIONS

In the small intestine and liver of the rat NASH model, the possibility that enhancement of the innate immune response, mediated by the TLR4 signal, led to increased production of TNF-α was suggested. This interaction between the small intestine and liver may be involved in the onset and progression of NASH.

摘要

背景

肠道菌群中革兰氏阴性杆菌的过度增殖和细菌易位,以及门脉血内毒素水平的升高,与非酒精性脂肪性肝炎(NASH)有关。

目的

使用大鼠 NASH 模型评估小肠和肝脏的固有免疫反应。

方法

我们通过给予 F344 大鼠胆碱缺乏型氨基酸定义饮食来产生 NASH 模型。我们分析了血清和肝组织,以评估该 NASH 模型中固有免疫反应的影响。

结果

NASH 组血清 ALT 水平以及门脉血清和全肝 TNF-α和 IFN-γ水平显著升高。NASH 组可见明显的天狼星红染色和 TNF-α免疫染色,实时 PCR 显示 NASH 组 TNF-α和 TLR4 mRNA 的表达明显增加。NASH 组分离培养的枯否细胞上清液中 TNF-α水平高于对照组。NASH 组回肠组织标本的免疫染色显示 TNF-α、TLR4 和巨噬细胞/树突状细胞的染色明显增加,主要位于黏膜下层。

结论

在大鼠 NASH 模型的小肠和肝脏中,提示 TLR4 信号介导的固有免疫反应增强导致 TNF-α产生增加的可能性。这种小肠和肝脏之间的相互作用可能参与 NASH 的发生和进展。

相似文献

1
Innate immune reactivity of the ileum-liver axis in nonalcoholic steatohepatitis.非酒精性脂肪性肝炎中回肠-肝脏轴的固有免疫反应性。
Dig Dis Sci. 2012 May;57(5):1144-51. doi: 10.1007/s10620-012-2073-z. Epub 2012 Feb 25.
2
Innate immune reactivity of the liver in rats fed a choline-deficient L-amino-acid-defined diet.喂食胆碱缺乏的L-氨基酸限定饮食的大鼠肝脏的天然免疫反应性
World J Gastroenterol. 2008 Nov 21;14(43):6655-61. doi: 10.3748/wjg.14.6655.
3
Immunotherapy for nonalcoholic steatohepatitis using the multiple cytokine production modulator Y-40138.使用多重细胞因子产生调节剂 Y-40138 治疗非酒精性脂肪性肝炎的免疫疗法。
World J Gastroenterol. 2009 Nov 28;15(44):5533-40. doi: 10.3748/wjg.15.5533.
4
Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice.髓样分化因子-2 和 Toll 样受体 4 表达缺失可减轻小鼠非酒精性脂肪性肝炎和肝纤维化。
Am J Physiol Gastrointest Liver Physiol. 2011 Mar;300(3):G433-41. doi: 10.1152/ajpgi.00163.2009. Epub 2011 Jan 13.
5
Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis.中药对非酒精性脂肪性肝炎大鼠内毒素及其受体的影响
Inflammation. 2008 Apr;31(2):121-32. doi: 10.1007/s10753-008-9057-3. Epub 2008 Feb 27.
6
Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.非酒精性或酒精性脂肪性肝炎所致肝损伤发展进程中的常见致病机制。
J Toxicol Sci. 2007 Dec;32(5):453-68. doi: 10.2131/jts.32.453.
7
Intestinal Trefoil Factor 3 Alleviates the Intestinal Barrier Function Through Reducing the Expression of TLR4 in Rats with Nonalcoholic Steatohepatitis.肠三叶因子 3 通过降低非酒精性脂肪性肝炎大鼠 TLR4 的表达减轻肠道屏障功能障碍。
Arch Med Res. 2019 Jan;50(1):2-9. doi: 10.1016/j.arcmed.2019.03.004. Epub 2019 Apr 4.
8
Effect of Soothing Gan (Liver) and Invigorating Pi (Spleen) Recipes on TLR4-p38 MAPK Pathway in Kupffer Cells of Non-alcoholic Steatohepatitis Rats.疏肝健脾方对非酒精性脂肪性肝炎大鼠库普弗细胞TLR4-p38 MAPK信号通路的影响
Chin J Integr Med. 2019 Mar;25(3):216-224. doi: 10.1007/s11655-018-2829-6. Epub 2018 Jan 9.
9
Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production.库普弗细胞通过产生肿瘤坏死因子-α触发饮食诱导的小鼠模型中非酒精性脂肪性肝炎的发生。
J Biol Chem. 2012 Nov 23;287(48):40161-72. doi: 10.1074/jbc.M112.417014. Epub 2012 Oct 12.
10
Cangju Qinggan Jiangzhi Decoction Reduces the Development of NonAlcoholic Steatohepatitis and Activation of Kupffer Cells.苍术清肝降脂汤减少非酒精性脂肪性肝炎的发生及库普弗细胞的激活。
Cell Physiol Biochem. 2018;48(3):971-982. doi: 10.1159/000491965. Epub 2018 Jul 23.

引用本文的文献

1
The immune response as a therapeutic target in non-alcoholic fatty liver disease.免疫反应作为非酒精性脂肪性肝病的治疗靶点。
Front Immunol. 2022 Oct 10;13:954869. doi: 10.3389/fimmu.2022.954869. eCollection 2022.
2
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.分子机制:非酒精性脂肪性肝病、脂肪性肝炎和肝细胞癌之间的联系。
Int J Mol Sci. 2020 Feb 23;21(4):1525. doi: 10.3390/ijms21041525.
3
Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?

本文引用的文献

1
Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis.TLR1-9 在果糖诱导的肝脂肪变性肝脏中升高。
Br J Nutr. 2012 Jun;107(12):1727-38. doi: 10.1017/S0007114511004983. Epub 2011 Oct 10.
2
Therapeutic effects of cytokine modulator Y-40138 in the rat alcoholic liver disease model.细胞因子调节剂 Y-40138 在大鼠酒精性肝病模型中的治疗效果。
J Gastroenterol Hepatol. 2011 Apr;26(4):775-83. doi: 10.1111/j.1440-1746.2011.06658.x.
3
Roles of liver innate immune cells in nonalcoholic fatty liver disease.
肠道菌群失调在肝脏疾病中的作用:我们目前了解到了什么?
Diseases. 2019 Nov 12;7(4):58. doi: 10.3390/diseases7040058.
4
Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease.人类非酒精性脂肪性肝病肠道微生物群中的粪便短链脂肪酸和产生短链脂肪酸的细菌,可能是全身T细胞活化和疾病进展的一个联系环节。
United European Gastroenterol J. 2018 Dec;6(10):1496-1507. doi: 10.1177/2050640618804444. Epub 2018 Sep 30.
5
Changes of Intestinal Functions in Liver Cirrhosis.肝硬化患者肠道功能的变化
Inflamm Intest Dis. 2016 Apr;1(1):24-40. doi: 10.1159/000444436. Epub 2016 Mar 8.
6
Relationship between intestinal flora and inflammatory factors in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者肠道菌群与炎症因子的关系
Exp Ther Med. 2018 Jan;15(1):723-726. doi: 10.3892/etm.2017.5490. Epub 2017 Nov 10.
7
Non-alcoholic fatty liver disease phosphoproteomics: A functional piece of the precision puzzle.非酒精性脂肪性肝病磷酸化蛋白质组学:精准难题中的一个功能板块。
Hepatol Res. 2017 Dec;47(13):1469-1483. doi: 10.1111/hepr.12885. Epub 2017 Apr 19.
8
Gut Microbiota and Host Reaction in Liver Diseases.肝脏疾病中的肠道微生物群与宿主反应
Microorganisms. 2015 Oct 28;3(4):759-91. doi: 10.3390/microorganisms3040759.
9
Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation.斯巴司他汀B通过激活NADPH氧化酶调节脂质筏中Toll样受体4(TLR4)的转运,从而减轻实验性非酒精性脂肪性肝炎(NASH)早期的肝脏炎症。
Am J Physiol Gastrointest Liver Physiol. 2016 Apr 1;310(7):G510-25. doi: 10.1152/ajpgi.00259.2015. Epub 2015 Dec 30.
10
A Lipidomic Readout of Disease Progression in A Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病饮食诱导小鼠模型中疾病进展的脂质组学解读
Trans Am Clin Climatol Assoc. 2015;126:271-88.
肝脏固有免疫细胞在非酒精性脂肪性肝病中的作用。
World J Gastroenterol. 2010 Oct 7;16(37):4652-60. doi: 10.3748/wjg.v16.i37.4652.
4
Immunotherapy for nonalcoholic steatohepatitis using the multiple cytokine production modulator Y-40138.使用多重细胞因子产生调节剂 Y-40138 治疗非酒精性脂肪性肝炎的免疫疗法。
World J Gastroenterol. 2009 Nov 28;15(44):5533-40. doi: 10.3748/wjg.15.5533.
5
Toll-like receptors as targets in chronic liver diseases.Toll样受体作为慢性肝病的治疗靶点
Gut. 2009 May;58(5):704-20. doi: 10.1136/gut.2008.156307.
6
Therapeutic approach to regulate innate immune response by Toll-like receptor 4 antagonist E5564 in rats with D-galactosamine-induced acute severe liver injury.通过 Toll 样受体 4 拮抗剂 E5564 调节内源性免疫反应治疗半乳糖胺诱导的急性重症肝损伤大鼠。
J Gastroenterol Hepatol. 2009 Jun;24(6):1089-94. doi: 10.1111/j.1440-1746.2008.05770.x. Epub 2009 Feb 15.
7
Innate immune reactivity of the liver in rats fed a choline-deficient L-amino-acid-defined diet.喂食胆碱缺乏的L-氨基酸限定饮食的大鼠肝脏的天然免疫反应性
World J Gastroenterol. 2008 Nov 21;14(43):6655-61. doi: 10.3748/wjg.14.6655.
8
Decreased phagocytic activity of Kupffer cells in a rat nonalcoholic steatohepatitis model.大鼠非酒精性脂肪性肝炎模型中库普弗细胞吞噬活性降低。
World J Gastroenterol. 2008 Oct 21;14(39):6036-43. doi: 10.3748/wjg.14.6036.
9
Expression of Toll-like receptor 4 in various organs in rats with D-galactosamine-induced acute hepatic failure.D-半乳糖胺诱导的大鼠急性肝衰竭各器官中Toll样受体4的表达
J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 2):e494-8. doi: 10.1111/j.1440-1746.2007.05246.x. Epub 2007 Dec 7.
10
Endotoxin modulates the capacity of CpG-activated liver myeloid DC to direct Th1-type responses.
Eur J Immunol. 2006 Sep;36(9):2483-93. doi: 10.1002/eji.200535767.